NEW YORK (GenomeWeb News) – Qiagen said today that it has formed a collaboration with the British Veterinary Laboratories Agency to commercialize a portfolio of PCR-based veterinary molecular assays outside the UK.

Under the terms of the deal, Qiagen has acquired a license to market seven assays for infectious veterinary diseases affecting livestock such as cows and horses. The assays are to be validated by VLA.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.